Questions with the most recent answer or edit.
I have now seen four different prices for the same product quoted as though each were the real one: a list price in the region of $1,300 a month, a "net price" figure…
The particulars: orforglipron · fourteen days. I have worked this out and I would like someone to find the error, because I suspect there is one. My working so far,…
Details up front: GGPeps · Chinese Peptide Company. I am trying to choose between two options that are usually discussed as though only one exists. I am not…
Setup, so nobody has to ask: identity confirmation by mass spectrometry · survodutide. I am at the decision point and I would rather think it through than improvise.…
I have three data points across nine months, which I hope is enough to see a trend. I suspect the usual explanation for this is wrong, or at least incomplete. I am…
Concretely: STEP 8 · 2.4 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…
Concretely: a 25G drawing needle · 8 mg/mL. Please show the division. I want to check my own against yours. I would like the general form as well as the specific…
What I am working with: aggregation · mazdutide · 2–8 °C. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I…
The case in front of me: 10 mg · 0.5 mL · 0.9% sodium chloride · a GLP-1 receptor agonist. I want to decide this in advance so that I am not deciding it under…
The case in front of me: GGPeps · Suzhou · the United States. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with…
I would like to know what to measure as much as what to do. I want to know whether there is evidence behind this or only repetition. I have checked the obvious…
What I am working with: SGN · BCH · Norway. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
The particulars: reflux · nine · mazdutide. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than discover a…
For reference: oral semaglutide · ten weeks · 40 °C. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have…
Nine weeks flat at 71.6 kg, from a start of 94 kg. Semaglutide 2.4 mg, month fourteen. Intake weighed, not estimated, at 1,650 kcal. Steps averaging 9,400. Three…
What I am working with: Janoshik · a GLP-1 receptor agonist. This is a procedural question rather than a theoretical one, and I would like the procedure rather than…
Stated plainly: 98.2% · batch certificate. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I…
I am trying to specify a method to a contract lab rather than accept their default, and I do not know enough to write a sensible specification. The choices I can see…
Stated plainly: SURPASS-3 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
The trend is what I care about; individual weeks are obviously noise. I have a result I cannot explain, and I would rather diagnose it than guess. I have checked the…
Conditions: chromatogram · MKM. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which I…
Conditions: 98.2% · method section. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
What I am working with: orforglipron · eight weeks · 25 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me…
The specifics, since they change the answer: tirzepatide · 37 °C · three days. I would like to define my thresholds before I have a result, for obvious reasons. I…